Derivatives of the Mouse Cathelicidin-Related Antimicrobial Peptide (CRAMP) Inhibit Fungal and Bacterial Biofilm Formation

Plant-Derived Decapeptide OSIP108 Interferes with Candida albicans Biofilm Formation without Affecting Cell Viability

(2014) N. Delattin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

More serious infectious morbidity and mortality associated with simultaneous candidemia and coagulase-negative staphylococcal bacteremia in neonates and in vitro adherence studies between Candida albicans and Staphylococcus epidermidis

(2014) David A. Kaufman et al.   EARLY HUMAN DEVELOPMENT

Chlorhexidine activity against bacterial biofilms

(2013) Pauline Cordenonsi Bonez et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities

(2013) Hilmar Wisplinghoff et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms

(2013) N. Delattin et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Biofilm infections, their resilience to therapy and innovative treatment strategies

(2013) U. Römling et al.   JOURNAL OF INTERNAL MEDICINE

Recent Approaches in Design of Peptidomimetics for Antimicrobial Drug Discovery Research

(2013) Sandeep Lohan et al.   MINI-REVIEWS IN MEDICINAL CHEMISTRY

The human antimicrobial peptide LL-37 and its fragments possess both antimicrobial and antibiofilm activities against multidrug-resistant Acinetobacter baumannii

(2013) Xiaorong Feng et al.   PEPTIDES

Identification of Peptides Derived from the Human Antimicrobial Peptide LL-37 Active against Biofilms Formed by Pseudomonas aeruginosa Using a Library of Truncated Fragments

(2012) C. Nagant et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The changing epidemiology of healthcare-associated candidemia over three decades

(2012) Daniel Diekema et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004–2008

(2012) Michael Pfaller et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Porphyromonas gingivalis: an invasive and evasive opportunistic oral pathogen

(2012) Nagihan Bostanci et al.   FEMS MICROBIOLOGY LETTERS

The Nonsteroidal Antiinflammatory Drug Diclofenac Potentiates the In Vivo Activity of Caspofungin Against Candida albicans Biofilms

(2012) Anna Bink et al.   JOURNAL OF INFECTIOUS DISEASES

Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective

(2012) Anders Folkesson et al.   NATURE REVIEWS MICROBIOLOGY

Antifungal Drug Discovery: Something Old and Something New

(2012) Arielle Butts et al.   PLoS Pathogens

Fungal Biofilms

(2012) Saranna Fanning et al.   PLoS Pathogens

Current Epidemiology and Growing Resistance of Gram-Negative Pathogens

(2012) David M. Livermore   KOREAN JOURNAL OF INTERNAL MEDICINE

LL37 and hBD-3 elevate the β-1,3-exoglucanase activity ofCandida albicansXog1p, resulting in reduced fungal adhesion to plastic

(2011) Hao-Teng Chang et al.   BIOCHEMICAL JOURNAL

Structure–activity relationship of 2-hydroxy-2-aryl-2,3-dihydro-imidazo[1,2-a]pyrimidinium salts and 2N-substituted 4(5)-aryl-2-amino-1H-imidazoles as inhibitors of biofilm formation by Salmonella Typhimurium and Pseudomonas aeruginosa

(2011) Hans P.L. Steenackers et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Novel fungicidal benzylsulfanyl-phenylguanidines

(2011) Karin Thevissen et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008–2009)

(2011) Michael A. Pfaller et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Antimicrobial and antibiofilm activity of LL-37 and its truncated variants against Burkholderia pseudomallei

(2011) Sakawrat Kanthawong et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Antifungal action of human cathelicidin fragment (LL13–37) on Candida albicans

(2011) Jack Ho Wong et al.   PEPTIDES

Human Antimicrobial Peptide LL-37 Inhibits Adhesion of Candida albicans by Interacting with Yeast Cell-Wall Carbohydrates

(2011) Pei-Wen Tsai et al.   PLoS One

Importance of Candida–bacterial polymicrobial biofilms in disease

(2011) Melphine M. Harriott et al.   TRENDS IN MICROBIOLOGY

Ability of Candida albicans Mutants To Induce Staphylococcus aureus Vancomycin Resistance during Polymicrobial Biofilm Formation

(2010) M. M. Harriott et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Epidemiology of Invasive Mycoses in North America

(2010) Michael A. Pfaller et al.   CRITICAL REVIEWS IN MICROBIOLOGY

Candida albicans and Staphylococcus aureus Form Polymicrobial Biofilms: Effects on Antimicrobial Resistance

(2009) M. M. Harriott et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vivo liberation of silver ions from metallic silver surfaces

(2009) Gorm Danscher et al.   HISTOCHEMISTRY AND CELL BIOLOGY

In vitro susceptibility of Burkholderia pseudomallei to antimicrobial peptides

(2009) Sakawrat Kanthawong et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Human cathelicidin peptide LL37 inhibits both attachment capability and biofilm formation ofStaphylococcus epidermidis

(2009) É. Hell et al.   LETTERS IN APPLIED MICROBIOLOGY

Brominated Furanones Inhibit Biofilm Formation by Salmonella enterica Serovar Typhimurium

(2008) J. C. A. Janssens et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Functional analysis of Candida albicans GPI-anchored proteins: Roles in cell wall integrity and caspofungin sensitivity

(2008) Armêl Plaine et al.   FUNGAL GENETICS AND BIOLOGY

Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation

(2008) J. Overhage et al.   INFECTION AND IMMUNITY

Biofilm lifestyle of Candida: a mini review

(2008) CJ Seneviratne et al.   ORAL DISEASES